Aflibercept
Pharmaceutical drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Aflibercept?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Aflibercept, sold under the brand names Eylea among others, is a medication used to treat wet macular degeneration and metastatic colorectal cancer.[10][11] It was developed by Regeneron Pharmaceuticals.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Eylea, Zaltrap |
Other names | ziv-aflibercept |
Biosimilars | aflibercept-jbvf,[1] aflibercept-yszy,[2] Opuviz,[2] Yesafili[1][3][4] |
AHFS/Drugs.com | Aflibercept Monograph Ziv-aflibercept Monograph |
MedlinePlus | a612004 |
License data |
|
Pregnancy category |
|
Routes of administration | Intravenous, intravitreal injection |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C4318H6788N1164O1304S32 |
Molar mass | 96898.57 g·mol−1 |
NY (what is this?) (verify) |
Close
It is an inhibitor of vascular endothelial growth factor (VEGF).[12][13]